GlassScriptPhysician profile
Brandy C Wilson
NPI 1770547580
$2,621.13
in general payments reported to CMS, 2019-2025
19 companies · $410 in 2025
The $410 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $389 · 2022: $785 · 2023: $518 · 2024: $519 · 2025: $410.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,447.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,446.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $570.44 | 2021-2023 | Endurant Iis |
| Janssen Pharmaceuticals, INC | $369.56 | 2021-2024 | Xarelto |
| W. L. Gore & Associates, INC. | $361.09 | 2022-2024 | Gore Tag Thoracic Branch Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $240.83 | 2021-2025 | Lifevest |
| Silk Road Medical, INC. | $191.10 | 2022 | |
| Atricure, INC. | $151.65 | 2025 | Atriclip Laa Exclusion System, Atricure Cryoice Cryosphere Cryoablation System, Epi-Sense Guided Coagulation System With Visitrax |
| Amgen INC. | $98.12 | 2022-2025 | Repatha |
| Pfizer INC. | $94.05 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $87.99 | 2022-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $82.61 | 2021-2025 | Farxiga, Brilinta, Wainua |
| Endologix LLC | $79.63 | 2025 | Alto Abdominal Stent Graft System |
| Glaxosmithkline, LLC. | $74.29 | 2023-2024 | Arexvy, Shingrix |
| E.R. Squibb & Sons, L.L.C. | $56.23 | 2021-2022 | |
| Boston Scientific Corporation | $48.14 | 2024 | Ekosonic, Watchman Flx |
| Smith+Nephew, INC. | $41.50 | 2024 | Pico 14, Pico 7, Renasys Touch |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $25.00 | 2024 | Cardiomems |
| Cardiva Medical, INC. | $17.34 | 2022 | |
| Novartis Pharmaceuticals Corporation | $15.82 | 2022 | |
| Gilead Sciences, INC. | $15.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandy Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.